Federal award
DIASORIN INC
W81K0223P0085
Contract
Obligated and Ceiling
- Obligated (net)
- $256,854.10
- Ceiling (potential value, not spending)
- $334,751.26
- Current value
- $334,751.26
- Gross positive obligations
- $324,362.02
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- DIASORIN INC · FGK2QR959BV5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- DIASORIN S.P.A. · KN6PH2K51SJ6
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0223P0085
- Award type code
- B
- Actions
- 13 · Jul 24, 2023 to Jun 12, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 12, 2026 | FY2026 | P00012 | B | $0.00 | — |
| Apr 2, 2026 | FY2026 | P00011 | M | $0.00 | — |
| Mar 23, 2026 | FY2026 | P00010 | M | $0.00 | — |
| Feb 18, 2026 | FY2026 | P00009 | B | $6,711.12 | — |
| Nov 26, 2025 | FY2026 | P00008 | C | $99,817.24 | — |
| Jul 17, 2025 | FY2025 | P00007 | G | $0.00 | — |
| Feb 7, 2025 | FY2025 | P00006 | M | $0.00 | — |
| Oct 28, 2024 | FY2025 | P00005 | B | $99,817.24 | — |
| May 7, 2024 | FY2024 | P00004 | B | −$67,507.92 | — |
| Apr 9, 2024 | FY2024 | P00003 | G | $0.00 | — |
| Oct 11, 2023 | FY2024 | P00002 | C | $99,817.24 | — |
| Aug 16, 2023 | FY2023 | P00001 | G | $0.00 | — |
| Jul 24, 2023 | FY2023 | 0 | — | $18,199.18 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.